The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-managem…

Lymphedema of the Head and Neck

~Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT06125743

Observational

Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema

The U.S. Food and Drug Administration approved photobiomodulation therapy (PBMT) as a treatment for breast cancer-related arm lymphedema (BCRL) in 2006. The in…

Head and Neck CancerLymphedema of the Head and Neck

~Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT06837480